Immunotherapy: CAR-modified T cells targeting CD19-curing the incurable
- PMID: 25348787
- DOI: 10.1038/nrclinonc.2014.187
Immunotherapy: CAR-modified T cells targeting CD19-curing the incurable
Comment on
-
Chimeric antigen receptor T cells for sustained remissions in leukemia.N Engl J Med. 2014 Oct 16;371(16):1507-17. doi: 10.1056/NEJMoa1407222. N Engl J Med. 2014. PMID: 25317870 Free PMC article. Clinical Trial.
References
-
- N Engl J Med. 2014 Oct 16;371(16):1507-17 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
